New study aims to reduce pneumonia risk in Tube-Fed kids
NCT ID NCT05455359
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This study looks at whether problems with how the stomach and esophagus move increase the risk of aspiration (food or liquid going into the lungs) in children with brain-related disabilities. It compares two drugs, prucalopride and famotidine, to see which better reduces symptoms like coughing and improves quality of life. The study involves 120 children aged 5 to 21 who get most of their nutrition through a feeding tube and are at high risk for aspiration pneumonia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPIRATION PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which feeding route cuts pneumonia risk after stroke?
- Three quick endoscopic checks may predict who still has reflux after surgery
- Leg raise test may predict acid reflux risk in obese patients before weight-loss surgery
- New device could make GERD diagnosis quicker and less painful
- Can fixing reflux fix your esophagus? new study investigates
- Anesthesia drug study halted after just 3 patients